Strategic Acquisition Miramar Labs was acquired by Sientra in 2017, expanding its backing and potential cross-sell opportunities within a larger aesthetic portfolio. Target buyers could leverage Sientra’s distribution channels and clinical network to accelerate miraDry adoption.

Market Expansion The miraDry system targets hyperhidrosis and underarm odor with a permanent, non-invasive solution, addressing a large, underpenetrated market in lifestyle aesthetics. Leverage this growth to approach dermatology clinics and medspas seeking differentiated offerings.

Economic Readiness With annual revenue in the low millions and substantial funding, there is appetite for channel investments and expansion. Explore partnerships, installation services, and co-marketing with existing distributors to scale deployment.

Operational Synergy Past collaborations with ServRight on hardware upgrades suggest an openness to turnkey field support. Propose service-level partnerships, training programs, and upgrade bundles to optimize unit uptime for clinics.

Competitive Position Compared to OTC solutions and temporary therapies, miraDry offers a unique, FDA-cleared, permanent reduction with minimal downtime. Position to high-value practices focusing on durable patient outcomes and differentiating from traditional deodorant or Botox approaches.